Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Rigel
to move arthritis drug forward; posts weak Q3 8:09 AM 11/3/2009
Reuters
Rigel Pharmaceuticals Inc will move ahead with a late-stage study of its
experimental arthritis pill R788 despite a failed mid-stage trial.
...
Zeltia's
Nypta gets orphan drug status 4:40 AM 11/3/2009
Reuters
Spanish biotech firm Zeltia's drug Nypta received orphan drug status from the European
Commission and the US FDA to treat progressive supranuclear palsy (PSP).
...
US
FDA issues alert on kidney problems with Byetta 4:32 PM 11/2/2009
Reuters
There are possible kidney function problems with Eli Lilly and Amylin
Pharmaceuticals' Byetta diabetes drug.
...
FDA
won't accept Merck's application for new drug 11:52 AM 11/2/2009
The Associated Press
The US FDA will not accept Merck's application for a new
combination cholesterol pill that includes rival Pfizer's Lipitor. Merck planned to make and market a
cholesterol pill combining Lipitor with Zetia.
...
Dendreon files in U.S.
for prostate cancer vaccine 8:32 AM 11/2/2009
Reuters
Dendreon Corp has completed its US regulatory submission for its experimental prostate
cancer vaccine Provenge.
...
SkyePharma: asthma drug
meets goal; EU filing on
track 6:33 AM 11/2/2009
Reuters
SkyePharma's asthma drug Flutiform met the main goals in a late-stage trial. It's on
track to apply for European regulatory approval in the first quarter of 2010.
...
Lupus
Drug Shows Promise in New Trial 5:08 AM 11/2/2009
New York Times
Human Genome Sciences said its experimental drug Benlysta to treat lupus was
effective in its second big clinical trial.
...
Takeda,
Amylin to Co-Develop Obesity Drugs 3:38 AM 11/2/2009
ABC News
Takeda Pharmaceutical and Amylin Pharmaceuticals will co-develop and commercialize
drugs to treat obesity including Amylin's pramlintide/metreleptin and davalintide in Phase II studies in the
United States.
...
Schering
hep C drug promising in Phase II study 2:52 PM 11/1/2009
Reuters
The combination of Schering-Plough Corp's experimental hepatitis C drug boceprevir and
the current treatments of pegylated-interferon and ribavirin appeared to knock out the virus at double the rate.
...
Vertex
hep C drug works well in twice daily dosing 12:07 PM 10/31/2009
Reuters
Vertex Pharmaceuticals Inc's hepatitis C drug telaprevir proved nearly as
effective in a twice daily regimen as three times a day.
...
Obama
frustrated with companies over flu vaccine 3:37 PM 10/30/2009
Reuters
Clueless in Washington. Having forced US-based companies out of the
vaccine market, HHS trusted estimates from the five foreign vaccine makers for the US market - AstraZeneca's
MedImmune, Sanofi-Aventis, Australia's CSL, GlaxoSmithKline, and Novartis.
...
Geron
hopes to restart stem-cell study in 2010 12:37 PM 10/30/2009
Forbes
Geron Corp hopes to pave the way for restarting human studies on a potential stem-cell
treatment for spinal cord injury by conducting additional preclinical studies by the third quarter of 2010.
...
Warner
Chilcott Completes Acquisition of P&G's Global Branded Prescription
... 7:42 AM 10/30/2009
Reuters
Almost 2000
employees of P&G's pharmaceuticals business joined Warner Chilcott. The company adds manufacturing facilities in
Germany and Puerto Rico.
...
Drug
Makers Face Tougher Measures 5:21 AM 10/30/2009
Wall Street Journal
The bills tax revenues not profits. Proposed rebates could lead to job
losses and cuts to R&D.
...
Aspirin
effect fuels concern over astrazeneca drug 5:40 PM 10/29/2009
Reuters
AstraZeneca's new blood thinner Brilinta may be less effective when
patients get a high dose of aspirin.
...
<- Day Earlier | Today's News
|
